Cargando…

P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA

Detalles Bibliográficos
Autores principales:	Mochkin, N., Sarzhevskiy, V., Protopopova, Y., Demina, E., Melnichenko, V., Bogatyrev, V., Samoylova, A., Mamedova, A., Rukavitsyn, A., Bannikova, A., Smirnova, E., Shorokhov, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428970/ http://dx.doi.org/10.1097/01.HS9.0000847232.50505.64

Ejemplares similares

P1367: COMPARISON CONDITIONING REGIMENS (BEEAC,LEAM,CLV) BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION FOR TREATMENT OF PRIMARY-REFRACTORY AND RELAPSED FORMS HODGKIN’S LYMPHOMA
por: Samoylova, A., et al.
Publicado: (2022)

P1366: NEW LYMPHOABLATIVE CONDITIONING REGIME FOR MULTIPLE SCLEROSIS – FIRST RESULTS FROM RUSSIAN PILOT STUDY
por: Rukavitcyn, A., et al.
Publicado: (2022)

Disseminated form of the Kaposi sarcoma in HIV-negative patient associated with Hodgkin’s lymphoma
por: Tutaeva, V V, et al.
Publicado: (2020)

Prevalence of allergen sensitization among 1,091 patients with urticaria
por: Ping, Jie-Dan, et al.
Publicado: (2020)

run 1091 26 GeV/c, R2, Test of luminescent screens in beam transfer for different beam intensities
por: Gottraux, J J, et al.
Publicado: (1980)

1091. An Ethnographic Approach to Interrogating Antimicrobial Stewardship at US Teaching Hospitals
por: Rynkiewich, Katharina, et al.
Publicado: (2019)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087
por: Chen, Robert, et al.
Publicado: (2015)

P1144: RADIOIMMUNOTHERAPY (RIT) VERSUS AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA: A FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III TRIAL.
por: Ladetto, M., et al.
Publicado: (2022)

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
por: Krishnan, A, et al.
Publicado: (2009)

Clinical characteristics and epidemiology of chronic urticaria: a nationwide, multicentre study on 1091 patients
por: Jankowska-Konsur, Alina, et al.
Publicado: (2019)

1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection
por: Bangash, Salman, et al.
Publicado: (2022)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin's Lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2021)

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
por: Marshall, A D, et al.
Publicado: (2017)

CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma
por: Martín-Moreno, Ana M., et al.
Publicado: (2015)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

Clinical Features of Severe Wasp Sting Patients with Dominantly Toxic Reaction: Analysis of 1091 Cases
por: Xie, Cuihong, et al.
Publicado: (2013)

Normal chest CT in 1091 symptomatic patients with confirmed Covid-19: frequency, characteristics and outcome
por: Leonard-Lorant, Ian, et al.
Publicado: (2021)

The Treatment of Multiple Myeloma Patients Not Eligible for Asct
por: Richardson, Paul, et al.
Publicado: (2010)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
por: Im, Soyoung, et al.
Publicado: (2022)

Bone marrow involvement by classic Hodgkin lymphoma posttransplant lymphoproliferative disorder
por: Lyapichev, Kirill A., et al.
Publicado: (2021)

Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
por: Gimsing, P, et al.
Publicado: (2015)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

Hemophagocytic Lymphohistiocytosis in a Patient with Classical Hodgkin Lymphoma
por: Hyun, G., et al.
Publicado: (2016)

The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
por: Meti, Nicholas, et al.
Publicado: (2018)

ASCT2 is the primary serine transporter in cancer cells
por: Conger, Kelly O., et al.
Publicado: (2023)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

The Grey Zones of Classic Hodgkin Lymphoma
por: Bosch-Schips, Jan, et al.
Publicado: (2022)

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018)

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
por: van Bladel, Diede A. G., et al.
Publicado: (2022)

A new mutation in BFSP2 (G1091A) causes autosomal dominant congenital lamellar cataracts
por: Ma, Xu, et al.
Publicado: (2008)

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers
por: Viviani, Simonetta, et al.
Publicado: (2022)

Successful autologous stem cell transplantation (ASCT) in a patient with juvenile dermatomyositis
por: Holzer, U, et al.
Publicado: (2008)

Rational design of ASCT2 inhibitors using an integrated experimental-computational approach
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2021)

Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist
por: Carreau, Nicole A., et al.
Publicado: (2019)

Combined linkage and association analysis of classical Hodgkin lymphoma
por: Lawrie, Alastair, et al.
Publicado: (2018)

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
por: Sun, Hong-Wei, et al.
Publicado: (2016)

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
por: Martynchyk, Arina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hs6ejqdiach6fss8e3347b0i1m